Anti-D Human Immunoglobulin, solution for injection, 300 mcg (1500 IU)/2 ml, in 2 ml

This tender concerns the procurement of Anti-D Human Immunoglobulin, a solution for injection, specified as 300 mcg (1500 IU) per 2 ml dose. The product falls under CPV code 33650000-1 (General anti-infectives for systemic use, vaccines, antineoplastics and immunomodulators). The procuring entity is the Communal Non-Profit Enterprise "Clinical Hospital No. 15 of the Podilskyi District of the City of Kyiv" of the Executive Body of the Kyiv City Council (Kyiv City State Administration). This medication is crucial for preventing Rh hemolytic disease of the newborn in Rh-negative women who have been exposed to Rh-positive blood. The tender specifies the exact dosage and presentation, requiring a sterile solution in a 2 ml vial. Bidders must supply pharmaceutical products that meet stringent quality standards and regulatory requirements for medicinal products. The procurement ensures the availability of this vital immunological agent for obstetric and gynecological care within the healthcare facility, safeguarding maternal and infant health.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals, Pharmaceuticals and Maternal Child Health. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 842,625.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.